Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M. F., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A. J. W., Donlan, R., and Schecter, W. P.: Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, JAMA Surgery, 152, 784–791, https://doi.org/10.1001/jamasurg.2017.0904, 2017. 

Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., Steinberg, J. P., and Weinstein, R. A.: American Society of Health-System Pharmacists, Infectious Disease Society of America, Surgical Infection Society, & Society for Healthcare Epidemiology of America, Clinical practice guidelines for antimicrobial prophylaxis in surgery, American journal of health-system pharmacy, AJHP, 70, 195–283, https://doi.org/10.2146/ajhp120568, 2013. 

Brothers, K. M., Parker, D. M., Taguchi, M., Ma, D., Mandell, J. B., Thurlow, L. L., Byrapogu, V. C., and Urish, K. L.: Dose optimization in surgical prophylaxis: sub-inhibitory dosing of vancomycin increases rates of biofilm formation and the rates of surgical site infection, Scientific Reports, 13, 4593, https://doi.org/10.1038/s41598-023-30951-y, 2023. 

Bunea, A., Lăptoiu, D., Târcomnicu, I., Oţelea, D., Popescu, G., and Marinescu, R.: In vivo systemic vancomycin determination from polymethyl methacrylate and morselized bone allograft used in two stage septic knee revision arthroplasty, Germs, 14, 294–300, https://doi.org/10.18683/germs.2024.1440, 2024. 

Chan, C., Lee, M. C., and Wong, J. Y.: Topical vancomycin in primary and revision total joint arthroplasty: a systematic review and meta-analysis, J. Arthroplasty, 39, 320–329, 2024.